Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings…
Flexsys Announces Price Increase for Insoluble Sulfur in India
AKRON, Ohio, June 18, 2025 /PRNewswire/ -- Flexsys has announced that it…
Red Cat Holdings Announces Closing of $46.75 Million Registered Direct Offering of Common Stock
June 18, 2025 16:05 ET | Source: Red Cat Holdings, Inc. SAN…
Vincerx Pharma, Inc. Announces Adjournment of Special Meeting – Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
The Block Announces Strategic Leadership Evolution as Leading Digital Asset News Platform Enters Next Growth Phase
Larry Cermak transitions to President role to focus on research and product…
Hyundai Motor Group Announces Grand Prix Recipient and Exhibitions of the 6th VH AWARD
Hyundai Motor Group premieres five commissioned artworks of the 6th VH AWARD…
Ubyx, The Stablecoin Clearing System Enabling Bank & Fintech Off-Ramps, Announces $10M Seed Led by Galaxy Ventures
Ubyx is founded by 30-Year Payments Veteran to Build Global Stablecoin Acceptance…
ValueLabs Announces Plans to Become the Enterprise OS of the Agentic Era
HYDERABAD, India, June 16, 2025 /PRNewswire/ -- ValueLabs, a global technology services…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
June 13, 2025 16:52 ET | Source: Vaxart, Inc. SOUTH SAN FRANCISCO,…
